薬物送達技術の北米市場:経口(固形)、経肺(噴霧器)、注射(機器)、経眼(機器)、経鼻(点滴薬)、局所(固形)、移植(能動)...市場調査レポートについてご紹介

【英文タイトル】North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 26)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Key Industry Insights
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 33)

4 Premium Insights (Page No. – 38)
4.1 North American Drug Delivery Technologies Market
4.2 North American Drug Delivery Technologies Market, By Route of Administration
4.3 North American Oral Drug Delivery Market, By Type
4.4 North American Pulmonary Drug Delivery Market, By Type
4.5 North American Injectable Drug Delivery Market, By Type
4.6 North American Ocular Drug Delivery Market, By Type
4.7 North American Nasal Drug Delivery Market, By Type
4.8 North American Topical Drug Delivery Market, By Type
4.9 North American Implantable Drug Delivery Market, By Type
4.10 North American Transmucosal Drug Delivery Market, By Type
4.11 North American Drug Delivery Technologies Market, By End User
4.12 North American Drug Delivery Technologies Market: Geographic Mix

5 Market Overview (Page No. – 45)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Rising Prevalence of Chronic Diseases
5.2.1.2 Launch of New Products in the Market
5.2.1.3 Technological Advancements
5.2.1.4 Growth in the Biologics Market
5.2.1.5 Funding Initiatives for Drug Delivery Research
5.2.2 Market Restraints
5.2.2.1 Risk of Needlestick Injuries and Side Effects Related to Drugs
5.2.3 Market Opportunities
5.2.3.1 Self-Administration and Home Care Drug Delivery
5.2.3.2 Rising Demand for Biosimilars and Generic Drugs
5.2.3.2.1 Biosimilars
5.2.3.2.2 Generic Drugs
5.2.3.3 Collaborations/Partnerships Among Companies
5.2.3.4 Improving the Bioavailability of Drugs
5.2.4 Market Challenges
5.2.4.1 Product Recalls
5.2.4.2 Patent Expiry and Patent Cliffs
5.2.5 Stringent Regulatory Approval Process

6 Regulatory Environment (Page No. – 58)
6.1 Introduction
6.2 Drug Approval
6.3 Device Approval

7 North American Drug Delivery Technologies Market, By Route of Administration (Page No. – 61)
7.1 Introduction
7.2 Oral Drug Delivery
7.2.1 Solid Oral Drugs
7.2.1.1 Tablets
7.2.1.2 Capsules
7.2.1.3 Pills
7.2.1.4 Powders
7.2.2 Liquid Oral Drugs
7.2.2.1 Syrups
7.2.2.2 Solutions
7.2.3 Semi-Solid Oral Drugs
7.2.3.1 Gels
7.2.3.2 Emulsions
7.2.3.3 Elixirs
7.3 Pulmonary Drug Delivery
7.3.1 Metered-Dose Inhalers
7.3.2 Dry Powder Inhalers
7.3.3 Nebulizers
7.3.3.1 Jet Nebulizers
7.3.3.2 Ultrasonic Nebulizers
7.3.3.3 Soft Mist Nebulizers
7.4 Injectable Drug Delivery
7.4.1 Injectable Drug Delivery Formulations
7.4.1.1 Novel Drug Delivery Formulations
7.4.1.2 Conventional Drug Delivery Formulations
7.4.1.3 Long-Acting Drug Delivery Formulations
7.4.2 Injectable Drug Delivery Devices
7.4.2.1 Conventional Injection Devices
7.4.2.1.1 Conventional Injection Devices, By Material
7.4.2.1.1.1 Glass
7.4.2.1.1.2 Plastic
7.4.2.1.2 Conventional Injection Devices, By Product
7.4.2.1.2.1 Fillable Syringes
7.4.2.1.2.2 Prefilled Syringes
7.4.2.1.3 Conventional Injection Devices, By Usability
7.4.2.1.3.1 Disposable Syringes
7.4.2.1.3.2 Reusable Syringes
7.4.2.2 Self-Injection Devices
7.4.2.3 Needle-Free Injectors
7.4.2.4 Wearable Injectors
7.4.2.5 Pen Injectors
7.4.2.6 Autoinjectors
7.4.3 Other Devices
7.5 Ocular Drug Delivery
7.5.1 Ocular Drug Delivery Formulations
7.5.1.1 Liquid Drug Delivery
7.5.1.1.1 Eye Drops
7.5.1.1.2 Liquid Sprays
7.5.1.2 Semi-Solid Drug Delivery
7.5.1.2.1 Gels
7.5.1.2.2 Eye Ointments
7.5.2 Ocular Drug Delivery Devices
7.5.2.1 Ocular Inserts
7.5.2.2 Contact Lenses Coated With Drugs
7.6 Nasal Drug Delivery
7.6.1 Nasal Sprays
7.6.2 Nasal Drops
7.6.3 Nasal Gels
7.6.4 Nasal Powders
7.7 Topical Drug Delivery
7.7.1 Semi-Solid Topical Drug Delivery
7.7.1.1 Creams
7.7.1.2 Gels
7.7.1.3 Ointments
7.7.1.4 Lotions
7.7.2 Transdermal Drug Delivery
7.7.2.1 Transdermal Patches
7.7.2.2 Transdermal Gels
7.7.3 Liquid Topical Drug Delivery
7.7.3.1 Solutions
7.7.3.2 Suspensions
7.7.4 Solid Topical Drug Formulations
7.7.4.1 Powders
7.7.4.2 Suppositories
7.8 Implantable Drug Delivery
7.8.1 Passive Implantable Drug Delivery
7.8.2 Active Implantable Drug Delivery
7.9 Transmucosal Drug Delivery
7.9.1 Oral Transmucosal Drug Delivery
7.9.1.1 Buccal Drug Delivery
7.9.1.2 Sublingual Drug Delivery
7.9.2 Other Transmucosal Drug Delivery
7.9.2.1 Rectal Transmucosal Drug Delivery
7.9.2.2 Vaginal Transmucosal Drug Delivery

8 North American Drug Delivery Technologies Market, By End User (Page No. – 138)
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers/Clinics
8.4 Home Care Settings
8.5 Other End Users

9 North American Drug Delivery Technologies Market, By Country (Page No. – 144)
9.1 Introduction
9.2 U.S.
9.3 Canada

10 Competitive Landscape (Page No. – 184)
10.1 Overview
10.2 Market Evolution Framework
10.3 Market Share Analysis
10.4 Competitive Situations and Trends
10.4.1 New Product Launches and Product Approvals
10.4.2 Partnerships, Agreements, and Collaborations
10.4.3 Acquisitions
10.4.4 Expansions
10.4.5 Other Strategies

11 Company Profiles (Page No. – 192)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Johnson & Johnson Services, Inc.
11.2 Novartis AG
11.3 F. Hoffmann-La Roche Ltd.
11.4 Pfizer, Inc.
11.5 Bayer AG
11.6 Antares Pharma, Inc.
11.7 Becton, Dickinson and Company
11.8 Glaxosmithkline PLC
11.9 3M Company
11.10 Merck & Co., Inc.
11.11 Sanofi

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 241)
12.1 Industry Insights
12.2 Discussion Guide
12.3 Other Recent Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports


【レポート販売概要】

■ タイトル:薬物送達技術の北米市場:経口(固形)、経肺(噴霧器)、注射(機器)、経眼(機器)、経鼻(点滴薬)、局所(固形)、移植(能動)
■ 英文:North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021
■ 発行日:2016年8月29日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-MD-4530
■ 調査対象地域:北米
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。